UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis (Q46769231)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2008

Language	Label	Description	Also known as
English	UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis	scientific article published in July 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

author name string

Elvira Bailón

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Mònica Comalada

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Juan Román

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Pedro Michelena

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Isabel Ramis

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Ana Nieto

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Angel Concha

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Antonio Zarzuelo

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

14

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

888-897

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

Inflammatory bowel disease: etiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Immunotherapeutic approaches to inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Medical therapy for ulcerative colitis 2004.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

UR-1505, a new salicylate, blocks T cell activation through nuclear factor of activated T cells.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Inflammatory bowel disease requires the interplay between innate and adaptive immune signals

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20381

21 January 2018

Identifiers

10.1002/IBD.20381

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18253952

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46769231&oldid=2130895956"